3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
3
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Head & Neck
1
Conditions
Leukemia, Myeloid, Acute
19
Breast Neoplasms
17
Advanced Solid Tumors
16
Advanced Solid Tumor
12
Carcinoma, Non-Small-Cell Lung
10
Myelodysplastic Syndromes
9
Uterine Cervical Neoplasms
6
Solid Tumor
6
Recurrence
6
Prostatic Neoplasms
6
Lymphoma, Large B-Cell, Diffuse
6
Triple Negative Breast Neoplasms
5
Stomach Neoplasms
5
Ovarian Neoplasms
5
Carcinoma, Hepatocellular
5
Small Cell Lung Carcinoma
4
Myeloproliferative Disorders
4
Multiple Myeloma
4
Advanced Solid Tumour
4
Advanced Malignant Solid Tumor
4
Solid Tumors
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Leukemia, Myelomonocytic, Chronic
3
Biliary Tract Neoplasms
3
Advanced Lung Cancer
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Interventions
tempol
1
maltodextrin
1
Xylitol
1
Radiotherapy, Intensity-Modulated
1
RRx-001
1
Injections
1
Folic Acid
1
Cisplatin
1
Betaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Mucositis
×
Injections
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled